Sumitomo Chemical India's Q3 Profit Slips; Stock Tests 52-Week Low

**
**

Market Reacts to Profit Contraction

Sumitomo Chemical India Ltd.'s shares succumbed to downward pressure following the release of its third-quarter financial results for the fiscal year 2026. The company reported a net profit of ₹75.6 crore, marking a significant 13% decrease compared to the ₹87 crore recorded in the same period last year. This profit erosion was accompanied by an 11% year-on-year revenue decline, with sales falling to ₹570 crore from ₹642 crore. The stock, trading at ₹413 on Tuesday, January 27, 2026, reflects a 1.26% dip for the day and a substantial 12% year-to-date loss for 2026, hovering near its 52-week low of ₹408.45.

Operating Performance Under Strain

Operating metrics also indicated challenges. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) slipped by 4.6% to ₹101.5 crore from ₹106.4 crore a year ago. Despite the top-line and bottom-line weakness, the company managed to improve its operating margins, which rose to 17.80% from 16.60% in the corresponding quarter of the previous year. This margin improvement, however, was not enough to offset the decline in sales volume and overall profitability, suggesting potential benefits from cost management or product mix adjustments on a reduced revenue base.

Sectoral Context and Competitive Positioning

The performance of Sumitomo Chemical India comes against a backdrop of a cautiously optimistic outlook for the broader Indian agrochemical industry. A recent report projects industry revenue growth of 6-7% for the fiscal year 2026, primarily fueled by a recovery in exports. Improved farm sentiment globally is expected to drive export revenues by 8-9%, although domestic demand faces headwinds from extended monsoon seasons, leading to crop damage and delayed field readiness. While Sumitomo Chemical India saw a revenue contraction, some competitors like UPL Ltd. reported positive quarterly profit growth year-on-year. Sumitomo Chemical India's Price-to-Earnings (P/E) ratio stands at approximately 38-39, which is higher than peers like UPL and PI Industries, indicating a comparatively richer valuation despite its recent performance struggles. The company's market capitalization is around ₹20,800-21,200 crore. Despite delivering a weaker Q3, some analysts maintain a positive outlook, with price targets suggesting significant upside potential, such as ₹630-690 from brokerages like Anand Rathi and Nirmal Bang. This sentiment may stem from the company's longer-term strategic positioning, including its proprietary product portfolio sourced from its Japanese parent and its integration with Excel Crop Care Limited, which has strengthened its domestic market presence. However, the company has also shown limitations, including poor profit growth of 4.99% and revenue growth of 0.33% over the past three years.

Financial Snapshot and Recent Activity

Sumitomo Chemical India's financials reveal a company that is virtually debt-free and maintains healthy return ratios like ROCE (around 25.1% to 25.77%) and ROE (around 18.8% to 19.18%). Its cash flow management and liquidity position are also considered robust. However, recent quarterly results, including the March 2025 quarter (Q4FY25), have also shown signs of pressure, with revenue growth being flat and EBITDA and PAT declining year-on-year. The company's board of directors met on January 27, 2026, to consider these latest quarterly financial results, a routine process for listed entities, with announcements regarding previous results and upcoming board meetings being a consistent feature in its investor relations disclosures.